Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 5Unknown 4Withdrawn 2Terminated 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 4Recurrence 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Liver Neoplasms 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Chemoembolization, Therapeutic × Clear all
NCT01393093 2017-06-12

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,840 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02631499 2015-12-22

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Fudan University

Phase 4 Unknown
256 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Recurrence

NCT01393197 2015-12-18

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,480 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡